SCD expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.454600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.294800E-01
Normal-vs-Stage2
2.511800E-01
Normal-vs-Stage3
2.841800E-01
Normal-vs-Stage4
1.677560E-01
Stage1-vs-Stage2
8.962400E-01
Stage1-vs-Stage3
6.831400E-01
Stage1-vs-Stage4
7.180800E-01
Stage2-vs-Stage3
5.182400E-01
Stage2-vs-Stage4
5.639600E-01
Stage3-vs-Stage4
8.983200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.555800E-01
Normal-vs-AfricanAmerican
3.730200E-01
Normal-vs-Asian
2.083400E-01
Caucasian-vs-AfricanAmerican
9.876900E-03
Caucasian-vs-Asian
7.030600E-01
AfricanAmerican-vs-Asian
9.372300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.060000E-01
Normal-vs-Female
2.785200E-01
Male-vs-Female
4.502400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.318000E-01
Normal-vs-Age(41-60Yrs)
2.530200E-01
Normal-vs-Age(61-80Yrs)
2.125400E-01
Normal-vs-Age(81-100Yrs)
1.845970E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.188000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.166600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.867400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.132400E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.788990E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.650400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.016200E-01
Normal-vs-Daily Drinker
3.403000E-01
Normal-vs-Weekly Drinker
2.243000E-01
Normal-vs-Occasional Drinker
1.004620E-01
Normal-vs-Social Drinker
2.989600E-01
Non Drinker-vs-Daily Drinker
6.194400E-01
Non Drinker-vs-Weekly Drinker
1.474200E-01
Non Drinker-vs-Occasional Drinker
6.899200E-01
Non Drinker-vs-Social Drinker
7.818400E-01
Daily Drinker-vs-Weekly Drinker
1.674220E-01
Daily Drinker-vs-Occasional Drinker
4.353200E-01
Daily Drinker-vs-Social Drinker
8.454400E-01
Weekly Drinker-vs-Occasional Drinker
2.666800E-01
Weekly Drinker-vs-Social Drinker
2.533400E-01
Occasional Drinker-vs-Social Drinker
5.953600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.083210E-01
Normal-vs-Grade 2
1.989210E-01
Normal-vs-Grade 3
9.273600E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.692300E-02
Grade 1-vs-Grade 3
4.437000E-01
Grade 1-vs-Grade 4
1.083210E-01
Grade 2-vs-Grade 3
1.476960E-01
Grade 2-vs-Grade 4
1.989210E-01
Grade 3-vs-Grade 4
9.273600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.985380E-01
Normal-vs-NonDiabetic
2.485400E-01
Diabetic-vs-NonDiabetic
2.847800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.270200E-01
Normal-vs-NoPancreatitis
2.369200E-01
Pancreatitis-vs-NoPancreatitis
8.946600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.643400E-01
Normal-vs-N1
2.647000E-01
N0-vs-N1
5.754600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.804800E-01
Normal-vs-TP53-NonMutant
9.542800E-01
TP53-Mutant-vs-TP53-NonMutant
8.220200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
